» Articles » PMID: 20059703

Direct Medical Cost of Overweight and Obesity in the USA: a Quantitative Systematic Review

Overview
Journal Obes Rev
Specialty Endocrinology
Date 2010 Jan 12
PMID 20059703
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

To estimate per-person and aggregate direct medical costs of overweight and obesity and to examine the effect of study design factors. PubMed (1968-2009), EconLit (1969-2009) and Business Source Premier (1995-2009) were searched for original studies. Results were standardized to compute the incremental cost per overweight person and per obese person, and to compute the national aggregate cost. A total of 33 US studies met review criteria. Among the four highest-quality studies, the 2008 per-person direct medical cost of overweight was $266 and of obesity was $1723. The aggregate national cost of overweight and obesity combined was $113.9 billion. Study design factors that affected cost estimates included use of national samples vs. more selected populations, age groups examined, inclusion of all medical costs vs. obesity-related costs only, and body mass index cut-offs for defining overweight and obesity. Depending on the source of total national healthcare expenditures used, the direct medical cost of overweight and obesity combined is approximately 5.0% to 10% of US healthcare spending. Future studies should include nationally representative samples, evaluate adults of all ages, report all medical costs and use standard body mass index cut-offs.

Citing Articles

Effect of Diet on HDL in Obesity.

Bacchetti T, Morresi C, Simonetti O, Ferretti G Molecules. 2025; 29(24.

PMID: 39770044 PMC: 11677490. DOI: 10.3390/molecules29245955.


Assessing the economic impact of obesity and overweight on employers: identifying opportunities to improve work force health and well-being.

Dall T, Sapra T, Natale Z, Livingston T, Chen F Nutr Diabetes. 2024; 14(1):96.

PMID: 39632835 PMC: 11618327. DOI: 10.1038/s41387-024-00352-9.


Association between sagittal abdominal diameter-to-height ratio and all-cause mortality among adults in the United States: a longitudinal study.

Gu X, Gao P, Zhu F, Shen Y, Lu L Arch Public Health. 2024; 82(1):213.

PMID: 39538327 PMC: 11562676. DOI: 10.1186/s13690-024-01443-w.


Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.

Zhou X, Chen Q, Yang W, Zuluaga M, Targher G, Byrne C EClinicalMedicine. 2024; 76:102848.

PMID: 39386160 PMC: 11462227. DOI: 10.1016/j.eclinm.2024.102848.


Estimated reduction in obesity prevalence and costs of a 20% and 30% ad valorem excise tax to sugar-sweetened beverages in Brazil: A modeling study.

Basto-Abreu A, Torres-Alvarez R, Barrientos-Gutierrez T, Pereda P, Duran A PLoS Med. 2024; 21(7):e1004399.

PMID: 39018346 PMC: 11253955. DOI: 10.1371/journal.pmed.1004399.


References
1.
Pronk N, GOODMAN M, OConnor P, Martinson B . Relationship between modifiable health risks and short-term health care charges. JAMA. 1999; 282(23):2235-9. DOI: 10.1001/jama.282.23.2235. View

2.
Long D, Reed R, Lehman G . The cost of lifestyle health risks: obesity. J Occup Environ Med. 2006; 48(3):244-51. DOI: 10.1097/01.jom.0000201568.73562.a2. View

3.
Allison D, Zannolli R, Narayan K . The direct health care costs of obesity in the United States. Am J Public Health. 1999; 89(8):1194-9. PMC: 1508703. DOI: 10.2105/ajph.89.8.1194. View

4.
WOLF A, Finer N, Allshouse A, Pendergast K, Sherrill B, Caterson I . PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample. Diabetes Obes Metab. 2008; 10(12):1248-60. DOI: 10.1111/j.1463-1326.2008.00895.x. View

5.
Finkelstein E, Fiebelkorn I, Wang G . National medical spending attributable to overweight and obesity: how much, and who's paying?. Health Aff (Millwood). 2003; Suppl Web Exclusives:W3-219-26. DOI: 10.1377/hlthaff.w3.219. View